16p11.2 copy number variation (CNV) is implicated in neurodevelopmental disorders, with the duplication and deletion associated with autism spectrum disorder (ASD) and the duplication associated with schizophrenia (SCZ). The 16p11.2 CNV may therefore provide insight into the relationship between ASD and SCZ, distinct disorders that co-occur at an elevated rate and are difficult to distinguish from each other and from common co-occurring diagnoses such as obsessive compulsive disorder (OCD), itself a potential risk factor for SCZ. As psychotic symptoms are core to SCZ but distinct from ASD, we sought to examine their predictors in a population (n = 546) of 16p11.2 CNV carriers and their noncarrier siblings recruited by the Simons Variation in Individuals Project. We hypothesized that psychotic symptoms would be most common in duplication carriers followed by deletion carriers and noncarriers, that an ASD diagnosis would predict psychotic symptoms among CNV carriers, and that OCD symptoms would predict psychotic symptoms among all participants. Using data collected across multiple measures, we identified 19 participants with psychotic symptoms. Logistic regression models adjusting for gender, age, and IQ found that 16p11.2 duplication and ASD diagnosis predicted psychotic symptom presence. Our findings suggest that the association between 16p11.2 duplication and psychotic symptoms is independent of ASD diagnosis and that ASD diagnosis and psychotic symptoms may be associated in 16p11.2 CNV carriers.
Introduction
difficult. Further, repetitive behaviors in ASD are sometimes difficult to distinguish from symp-performed Fisher's exact test to assess the strength of their relationship. private thoughts," and "having thoughts that are not your own." We considered a response of 136 at least "a little bit" to any of these items to be a positive screen.
137
DISC: For each DSM-IV diagnosis assessed by the DISC interview, data were available 138 regarding the number of symptoms endorsed but not which were endorsed specifically. We 139 considered endorsement of at least one schizophrenia symptom within the past year to represent 140 a positive screen. 141 M-SOPS: Five M-SOPS items assess symptoms of psychosis: "unusual thought content 142 or delusional ideas," "suspiciousness or persecutory ideas," "grandiosity," "perceptual abnor-143 malities or hallucinations," and "disorganized communication." The presence of at least one of these symptoms (with the exception of "disorganized communication," which we did not consider given its non-specificity) represented a positive screen.
Versions one and three of the index did not incorporate an age cutoff. However, since true psychosis in young children is rare, with childhood-onset schizophrenia typically not present- 148 ing before age seven (Baribeau & Anagnostou, 2013) , versions two and four required that a 149 participant be at least seven years old to be positively identified with psychotic symptoms. As index version four was the most stringent, incorporating both the raised CBCL threshold 152 and the age cutoff, we used it to identify participants likely to have psychotic symptoms. We 153 then examined predictors of the presence of psychotic symptoms by conducting a series of 154 logistic regressions. All models used generalized estimating equations (GEEs) to control for 155 intra-family correlations (Hanley, Negassa, deB Edwardes, & Forrester, 2003) .
156
Our predictor variables of interest, which we selected a priori, were CNV carrier status, age, 157 IQ, clinical ASD diagnosis, OCD symptoms (as measured by endorsement of at least one OCD 158 symptom in the past year during the DISC interview) and gender. Prior to conducting any 159 analyses, we ruled out multicollinearity by inspecting the correlation matrix between scaled 160 versions of all variables.
161
Our primary analysis included four regression models. The first was estimated for the 162 entire sample, and included all predictors of interest. The second, third and fourth models 163 were estimated for subgroups of the sample defined by carrier status (i.e., 16p11.2 deletion 164 carriers, 16p11.2 duplication carriers, and noncarriers), and each included all predictors of 165 interest except carrier status. All analyses used unscaled variables for ease of interpretability. To determine whether ASD severity could predict the presence of psychotic symptoms, we esti-168 mated exploratory regression models that substituted the categorical ASD diagnosis predictor 169 with continuous ADOS CSS values.
170
Total CSS values for participants who received ADOS Modules 1, 2 or 3 were available to 171 us as part of the Simons VIP dataset. For those who received ADOS Module 4, we derived 172 total CSS values from item-level data . For all ADOS modules, we derived participants who did not receive the ADOS were excluded from exploratory models in which total CSS was a predictor. An additional 59 participants who lacked item-level data were 176 excluded from models in which domain CSS values were predictors. We conducted all analyses in R 3.5.1 (R Core Team, 2018), using functions from dplyr 0.7.8 179 (Wickham, François, Henry, & Müller, 2018) , magrittr 1.5 (Bache & Wickham, 2014) , and purrr 180 0.2.5 (Henry & Wickham, 2019) , as well as chisq.post.hoc from fifer 1.1 (Fife, 2019) , rescale 181 from arm 1.10-1 (Gelman et al., 2018) , geeglm from geepack 1.2-1 (Hojsgaard, Halekoh, & Yan, 182 2016), and tidy from broom 0.5.0 (Robinson et al., 2018) . Analysis scripts are available from Hypothesis 3, that OCD symptoms would predict the presence of psychotic symptoms among 232 both carriers and noncarriers, was not significantly supported by our findings. among noncarriers (OR 0.93 for every year increase in age, 95% CI 0.87 -0.99, p = 0.02), but 237 as only three noncarriers had psychotic symptoms, this finding is likely to be artifactual. The parameters of exploratory models that substituted categorical ASD diagnosis with contin-240 uous ADOS Calibrated Severity Scores (CSS) are presented in Table S2 (for total CSS) and 241   Table S3 (for domain CSS).
242
Total CSS trended toward significance as a predictor of psychotic symptoms among all 243 participants who received the ADOS (OR 1.21 for every one point increase in CSS, 95% CI 244 0.99 -1.47, p = 0.06). We did not find that domain CSS for RRB or SA were significant 245 predictors. The specific focus on a rare genetic variant allowed us to minimize underlying genetic heterogeneity in exploring the relationship between ASD and risk of psychotic symptoms. Further, 283 we tested convergent validity across multiple measures within our psychotic symptom index. 284 We also were able to verify the stability of our results using alternate versions of the composite 285 psychotic symptom index with different levels of stringency.
286
This study also has important limitations. Our focus on a rare CNV, despite its advantages, 287 necessarily restricted our sample size, which in turn restricted the statistical power we could Table S3 : ADOS domain calibrated severity scores as predictors of psychosis
